SCHEMBL7035784

SCHEMBL7035784

Cc1ccccc1C(=NO)c1ccc(Nc2cccnc2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.52
MAPK13 O15264 9/20 0.52
MAPK12 P53778 9/20 0.52
MAPK11 Q15759 9/20 0.52
NPC1 O15118 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CCNK O75909 1/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CCND3 P30281 1/20 0.42
CDK9 P50750 1/20 0.42
CDK6 Q00534 1/20 0.42
CYP11B2 P19099 2/20 0.42
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
BRAF P15056 1/20 0.39
CSF1R P07333 1/20 0.39
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036523 0.88 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7037510 0.87 MAPK14 (0.50) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7035645 0.87 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1907236 0.87 MAPK14 (0.67) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7036392 0.85 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7038369 0.85 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7038525 0.84 KDM4E (0.45) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7038995 0.84 MAPK14 (0.47) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7040292 0.84 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7036540 0.84 MAPK14 (0.75) MAPK14MAPK13MAPK12MAPK11NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA MAPK14 625/4885MAPK13 1908/4885MAPK12 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.